Gardasil Granted Priority Review

Merck's human papillomavirus vaccine Gardasil has been granted priority review by FDA, the company announced Feb. 7

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet